Plaintiffs' lawyers are gearing up for a slew of pharmaceutical product liability trials in 2010. While no case has the magnitude of the massive $4.85 billion Vioxx settlement in 2007, the trials represent a welcome return to courtroom action on the pharmaceutical front for plaintiffs' lawyers.Read More »
Pfizer, Inc., the world’s biggest drugmaker, goes to trial today on claims its epilepsy medication Neurontin increases the risk of suicide, in a case the judge called “very tough” for the plaintiffs to win. The trial will be the first of what plaintiffs’ lawyers say are about 1,200 cases.
Tagged with: NeurontinRead More »